Filing Details
- Accession Number:
- 0000899243-22-001651
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-11 21:11:44
- Reporting Period:
- 2022-01-11
- Accepted Time:
- 2022-01-11 21:11:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1827087 | Vigil Neuroscience Inc. | VIGL | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1451612 | Bruce Booth | Vigil Neuroscience, Inc. 1 Broadway, 7Th Floor, Suite 07-300 Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-01-11 | 2,831,520 | $0.00 | 4,273,896 | No | 4 | C | Indirect | By Atlas Venture Fund XII, L.P. |
Common Stock | Acquisiton | 2022-01-11 | 1,027,978 | $0.00 | 1,027,978 | No | 4 | C | Indirect | By Atlas Venture Opportunity Fund I, L.P. |
Common Stock | Acquisiton | 2022-01-11 | 535,000 | $14.00 | 4,808,896 | No | 4 | P | Indirect | By Atlas Venture Fund XII, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | By Atlas Venture Fund XII, L.P. |
No | 4 | C | Indirect | By Atlas Venture Opportunity Fund I, L.P. |
No | 4 | P | Indirect | By Atlas Venture Fund XII, L.P. |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2022-01-11 | 7,852,374 | $0.00 | 2,831,520 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2022-01-11 | 2,850,789 | $0.00 | 1,027,978 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a one-for-2.7732 basis upon the closing of the Issuer's initial public offering on January 11, 2022 and had no expiration date.
- These shares are held directly by Atlas Venture Fund XII, L.P. ("Atlas Venture Fund XII"). The general partner of Atlas Venture Fund XII is Atlas Venture Associates XII, L.P. ("AVA XII LP"). Atlas Venture Associates XII, LLC ("AVA XII LLC") is the general partner of AVA XII LP. The Reporting Person is a member of AVA XII LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund XII, except to the extent of his pecuniary interest therein, if any.
- The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. The Reporting Person is a member of AVAO I LLC and disclaims beneficial ownership of such securities held by Atlas Venture Opportunity Fund I, except to the extent of his pecuniary interest therein, if any.
- On January 11, 2022, Atlas Venture Fund XII purchased 535,000 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.